human breast cancer cell lines bt474 Search Results


90
Pharmaron Beijing Co bt-474 human breast cancer cell lines
Bt 474 Human Breast Cancer Cell Lines, supplied by Pharmaron Beijing Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+breast+cancer+cell+lines+bt474/us08198301-160-0-15?v=Pharmaron+Beijing+Co
Average 90 stars, based on 1 article reviews
bt-474 human breast cancer cell lines - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Beuth Verlag GmbH human ductal breast carcinoma cell line bt474
Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.
Human Ductal Breast Carcinoma Cell Line Bt474, supplied by Beuth Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+breast+cancer+cell+lines+bt474/pmc04127267-147-10-2?v=Beuth+Verlag+GmbH
Average 90 stars, based on 1 article reviews
human ductal breast carcinoma cell line bt474 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank bt474 cells
KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of <t>MB231</t> cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.
Bt474 Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+breast+cancer+cell+lines+bt474/pmc07136911-58-7-13?v=JCRB+Cell+Bank
Average 90 stars, based on 1 article reviews
bt474 cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
CLS Cell Lines Service GmbH human breast carcinoma, ductal cell line bt-474
KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of <t>MB231</t> cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.
Human Breast Carcinoma, Ductal Cell Line Bt 474, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+breast+cancer+cell+lines+bt474/custom%40300131%4031789396?v=CLS+Cell+Lines+Service+GmbH
Average 93 stars, based on 1 article reviews
human breast carcinoma, ductal cell line bt-474 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.

Journal: BioMed Research International

Article Title: Preclinical and Clinical Effects of Mistletoe against Breast Cancer

doi: 10.1155/2014/785479

Figure Lengend Snippet: Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.

Article Snippet: In 2006, Beuth et al. [ ] studied the human ductal breast carcinoma cell line BT474 and proved the direct antitumor efficacy of Helixor M and Helixor A using a calorimetric in vitro assay.

Techniques: In Vitro, In Vivo, Activity Assay, Purification, Inhibition, Transplantation Assay

KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of MB231 cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival

doi:

Figure Lengend Snippet: KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of MB231 cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.

Article Snippet: Cell culture MCF10A, MCF7, SKBR3, BT474, and MB231 cells were obtained from the JCRB (Japanese Collection of Research Bioresources) Cell Bank.

Techniques: Expressing, Transfection